Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

McKesson Corp. Revealed as the Clear Lake, Iowa Mystery Company

February 19, 2015 2:24 pm | News | Comments

Officials said Thursday that San Francisco-based McKesson Corp. would occupy a new 340,000-square-foot distribution center in Clear Lake, ending a nearly yearlong mystery about the company's identity.

TOPICS:

TepoFlex® Polyethylene-Based Biocontainer Assemblies

February 19, 2015 1:51 pm | by Meissner Filtration Products, Inc. | Meissner Filtration Products, Inc. | Product Releases | Comments

TepoFlex® polyethylene (PE) biocontainer assemblies provide secure, robust fluid handling options. TepoFlex® polyethylene-based biocontainers are available in standard assembly designs from 50 mL to 1,000 L, utilizing the exact same materials of construction throughout the entire portfolio. This streamlines scale- up efforts so that...

FDA Expands Indication for REVLIMID®

February 19, 2015 11:46 am | News | Comments

Celgene Corporation has announced that the FDA has expanded the existing indication for REVLIMID® (lenalidomide) in combination with dexamethasone to include patients newly diagnosed with multiple myeloma (NDMM).

TOPICS:
Advertisement

Measles Case Triggers Student Quarantine

February 19, 2015 9:04 am | Videos | Comments

A dozen unimmunized students in Port Angeles, Washington have been asked to stay home, after a classmate was exposed to measles.

Could Germs Be Hiding in Store Makeup-Testers?

February 19, 2015 8:59 am | Videos | Comments

"GMA" contributor Becky Worley went undercover to see how clean free makeup testers really are.

NewLink Announces Clinical Development Milestone Achieved With Merck for Ebola Vaccine Candidate

February 19, 2015 8:51 am | News | Comments

Under the terms of the agreement, NewLink Genetics will receive a payment of $20 million in connection with the achievement of the milestone. The milestone pertains to the initiation of a key clinical trial for the vaccine.

TOPICS:

Florida Has Highest Number of Enrollees Under Health Law

February 19, 2015 8:47 am | by KELLI KENNEDY, Associated Press | News | Comments

Florida has eclipsed California to become the state with the highest number of consumers buying health coverage through new insurance markets under the Affordable Care Act, according to federal statistics released Wednesday.

TOPICS:

Seven Infected, Two Dead After 'Superbug' Outbreak at Hospital

February 19, 2015 8:42 am | by ROBERT JABLON, Associated Press | News | Comments

Contaminated medical instruments are to blame for infecting seven patients — including two who died — with an antibiotic-resistant and potentially deadly "superbug" at Ronald Reagan UCLA Medical Center, hospital officials said. A total of 179 patients may be infected.

TOPICS:
Advertisement

FDA Issues Warning as Peanuts Found in Cumin Spice

February 19, 2015 8:28 am | by MARY CLARE JALONICK, Associated Press | News | Comments

Hundreds of products are being pulled from store shelves after traces of peanut were found in cumin spice — a life-threatening danger to some people with peanut allergies.

TOPICS:

Kite Pharma Establishes Manufacturing Capabilities to Support Cancer Immunotherapy Products

February 19, 2015 8:25 am | News | Comments

Kite Pharma has entered into a lease agreement for a commercial manufacturing facility in El Segundo, California, which is adjacent to Los Angeles International Airport.

TOPICS:

FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf in Advanced Melanoma

February 19, 2015 8:18 am | News | Comments

Genentech, a member of the Roche Group, announced the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company’s New Drug Application (NDA) for cobimetinib in combination with Zelboraf ® (vemurafenib) for the treatment of people with BRAF V600 mutation-positive advanced melanoma

TOPICS:

Does More Money Equal More Cures?

February 18, 2015 3:30 pm | by Mike Auerbach, Editor-In-Chief | Blogs | Comments

In July of this year it will be six years since my father dies from pancreatic cancer. As I write this in late February it’s been four weeks since my father-in-law passed away from mesothelioma, a cancer caused by exposure to asbestos.

TOPICS:

Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Products from BioSET

February 18, 2015 2:14 pm | News | Comments

Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET), including two phase III ready orthobiologic product candidates designed to improve bone repair.

TOPICS:

China’s Colorectal Cancer Treatment Market Value to Exceed $1 Billion by 2023, says GlobalData

February 18, 2015 8:57 am | News | Comments

The Chinese treatment market for colorectal cancer (CRC) will expand almost fourfold in value from an estimated $259 million in 2013 to $1.05 billion by 2023, at an impressive Compound Annual Growth Rate (CAGR) of 15.1%, according to research and consulting firm GlobalData.

TOPICS:

Chemical Spray Tans May Pose Health Risk

February 18, 2015 8:39 am | Videos | Comments

Could misuse of the popular beauty treatment have impact on your health?

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading